The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice

This publication has 11 references indexed in Scilit:

• Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin
  New England Journal of Medicine, 2001
• Circulating Matrix Metalloproteinases and Their Inhibitors in Patients with Kawasaki Disease
  Circulation, 2001
• Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure—modulatory effect of intravenous immunoglobulin
  Journal of the American College of Cardiology, 2001
• Adverse Effects of Intravenous Immunoglobulin Therapy in 56 Patients with Autoimmune Diseases
  Pharmacology, 2001
• Lack of Skin Fibrosis in Tight Skin (TSK) Mice with Targeted Mutation in the Interleukin-4Rα and Transforming Growth Factor-β Genes
  Journal of Investigative Dermatology, 2001
• Skin Score Decrease in Systemic Sclerosis Patients Treated with Intravenous Immunoglobulin - A Preliminary Report
  Clinical Rheumatology, 2000
• Downregulation of TGF-β1 mRNA and Protein in the Muscles of Patients with Inflammatory Myopathies after Treatment with High-Dose Intravenous Immunoglobulin
  Clinical Immunology, 2000
• The Vascular Perspective of Systemic Sclerosis: Of Chickens, Mice and Men
  International Archives of Allergy and Immunology, 1999
• POOLED HUMAN IMMUNOGLOBULIN INHIBITS IL-4 BUT NOT IFN-γ OR TNF-α SECRETION FOLLOWING IN VITRO STIMULATION OF MONONUCLEAR CELLS WITH STAPHYLOCOCCAL SUPERANTIGEN
  Cytokine, 1999
• Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis.
  The Journal of Immunology, 1994